Connected-Medtech Design-Authority Transfer Leader

The mandate

India teams now build much of a connected-device platform, yet Korean systems leaders retain interface, cybersecurity, risk and release decisions while quality approvals follow a separate path. A field correction stalled because no owner could adjudicate device-cloud evidence, and the transfer executive resigned after India accepted delivery targets without corresponding design authority.

The interim must start in Seoul within three weeks and lead for sixteen months, with a possible two-month extension only if the final regulatory release moves. A permanent global design-transfer search begins after India owns one subsystem through field correction and release, expected in month nine. The successor will overlap for eight weeks.

Handover requires two device-cloud subsystems to have accountable India design owners, quality and regulatory independence to remain explicit, supplier and evidence access to be usable, source shadow decisions to exit, two correction and release simulations to pass, and the permanent leader to accept design, talent, control and residual-risk registers.

The interim may stop transfers, reject subsystem acceptance, set design and evidence forums, redirect existing engineers and approve up to KRW 28 billion within the programme. Permanent hiring, product claims, regulatory submission, supplier termination and decisions above KRW 6 billion require board approval. The seat cannot sign quality release or alter patient-safety policy.

Hardware manufacturing, commercial market entry, clinical evaluation and products outside the named subsystems are explicitly out of scope. The mandate covers device-cloud design authority, systems interfaces, cybersecurity engineering, quality collaboration, supplier knowledge, India leadership and permanent transfer governance.

Why this seat is open

The field correction exposed engineering activity without an accountable cross-system decision owner in India. Leadership departure left quality cautious, source experts overloaded and India leaders unable to close evidence. Temporary authority is needed to transfer a complete design scope, exercise it under correction pressure and hand permanent leadership a credible global role.

What you will own

• Map device, cloud, interface, cybersecurity, risk, verification, quality and supplier decisions across source teams and India subsystem owners.
• Define subsystem design authority with thresholds for interface change, field defect, cyber risk, clinical evidence and escalation.
• Preserve independent quality and regulatory approval while moving routine engineering judgment, risk analysis and accountable disposition.
• Transfer supplier, tool, traceability, complaint, field-performance and design-history access needed for complete subsystem ownership.
• Build India systems, software, cybersecurity and product leaders with exercised cover for correction and release decisions.
• Command correction, threat, interface-failure and release-readiness scenarios that reveal hidden source approvals or missing records.
• Transfer design ledgers, assurance evidence, delegations, talent decisions, supplier actions and exceptions through successor-chaired design reviews.

Candidate qualifications

• Led design-authority transfer for regulated connected devices or safety-relevant device-cloud systems during marketed-product obligations.
• Moved systems, interface, cybersecurity, complaint investigation and defect-disposition decisions into an India engineering centre.
• Preserved independent quality and regulatory approval without leaving routine technical judgment or risk analysis abroad.
• Resolved field-evidence, design-history, tool and supplier-access gaps that prevented complete receiving-team accountability.
• Built India technical leaders credible with clinicians, quality officers and source engineers during correction and global release reviews.
• Handed transferred design scope to permanent leadership after observing corrective action, threat assessment and release cycles.

Non-negotiables

• Can start in Seoul within three weeks and travel monthly between Korean and Indian engineering sites.
• Will accept exclusive executive responsibility and continuous escalation for affected field and release decisions.
• Brings regulated medtech design-authority transfer; software outsourcing management alone is insufficient.
• Must disclose relationships with device manufacturers, quality advisers, suppliers and engineering firms.

1. 49 words maximum. State your earliest Seoul start and the largest regulated design scope you transferred into India.
2. 49 words maximum. Describe a field correction that exposed missing design authority in the receiving centre.
3. 49 words maximum. Which quality decision must remain independent after engineering authority moves?